Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Cube predicts doubling of institutional investment in hedge funds

Monday, March 07, 2011

By Beverly Chandler, Opalesque London:

London based global alternative investment firm, Cube Capital, has expanded its offering to outside investors, having discovered, since 2008, that investors like what it is offering. In a recent announcement, the firm declared that it expects the average pension fund allocation to hedge funds, which currently stands at 5% in the US and slightly less than that in Europe, to double over the next three years.

Other predictions include that those allocating for the first time will use funds of funds as that does not require additional resources from the plan sponsor or an additional specialist consultant and has been a successful path for their peers and that those increasing their allocations will use a mix of direct hedge funds and niche fund of hedge funds as satellites to complement their existing core exposure with the more generic asset allocator fund of hedge funds.

Peter Madsen, director of business development with $1.2bn Cube Capital explains that the firm was founded in 2003 by three partners from the investment management and banking world to look after the assets of a group of high net worth investors. In 2010, the firm decided to open their services up to outside investors and now 10% of their money under management comes from pensions and charities based in the UK and the US.

"Our experience in 2008 and 2009 made us realise that we had more one of the more competitive offerings around in the market pl......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for